Middle Molecule Find

Rulebook › V-tags › V351

V351 Germicide presence: process control and sampling

Written V0351 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 170 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR 494.50(b)(1)

12.3.2 Process control and sampling (testing for presence of germicide)

[If a germicide manufacturer does not require testing each hemodialyzer for the presence of germicide before the rinsing step], the presence of germicide may be ensured by a direct presence test of each hemodialyzer or the use of process control and sampling of the dialyzer for germicide. Sections 12.3.2.1 and 12.3.2.2 provide examples of what can be used to comply with this requirement..

12.3.2.1 Process control

  • Use hemodialyzer germicide filling equipment with on-line automatic monitors during the germicide dilution and hemodialyzer filling process; or
  • Use an indicator substance (e.g., FD&C Blue #1), which has been added to the germicide, and that reliably indicates the presence of germicide. If blue dye is used, it should be added to the germicide concentrate before dilution, not to the fully diluted solution.

12.3.2.2 Sampling for process validation

  • Sample at least one hemodialyzer per patient shift per reuse system with a direct presence test. Do not use a Schiff test for formaldehyde for this purpose because a positive test result does not necessarily demonstrate the presence of an adequate concentration of formaldehyde. Samples should be taken immediately after the dialyzers have been reprocessed.
  • For germicide prepared in batches, sample at least one hemodialyzer from each batch with a direct presence test. Samples should be taken immediately after the dialyzers have been reprocessed.
  • Sampling and testing are to be accomplished before patients use any hemodialyzers processed on this shift.

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

ANSI/AAMI RD47:2 002/A1:2003

12.3.2.1 Process control

Note that use of dye may be inappropriate with certain germicides such as peracetic acid.

12.3.2.2 Sampling for process validation

NOTE— The requirements of this section are fulfilled if every dialyzer is subjected to post-storage/pre-priming direct presence testing.

Additional Guidance:

This tag refers to procedures that may be used to validate that dialyzers, reprocessed with germicides that don't require the presence testing of each dialyzer, are adequately disinfected and safe for use. If each dialyzer is not tested for germicide presence, procedures for both process control and testing a sample of dialyzers for germicide concentration are required.

For certain germicides, the facility may use a blue dye (as process control) to indicate the presence of germicide in the dialyzers. The absence of blue coloring should not be used as the sole indicator of the absence of germicide. Any process control procedure should be used in conjunction with a procedure for testing a sample of dialyzers, as described in this tag.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 170 (the full 469-page PDF) before quoting it.